Egetis Therapeutics AB (publ) (STO:EGTX)

Sweden · Delayed Price · Currency is SEK

5.17

+0.05 (0.98%)

Feb 10, 2026, 5:29 PM CET

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '10 Dec 31, 2010
Emcitate	46.10M
Emcitate Growth	-19.97%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '10 Dec 31, 2010
Germany	29.40M
Germany Growth	73.96%
France	6.40M
France Growth	10.34%
Spain	4.00M
Spain Growth	-20.00%
Poland	1.90M
Poland Growth	-26.92%
Other Countries	1.70M
Other Countries Growth	-63.83%
Australia	1.50M
Australia Growth	-40.00%
United Kingdom	600.00K
United Kingdom Growth	-75.00%
Sweden	500.00K